Vale Biolabs
Switzerland · Biotech · AI
Vale Biolabs develops human brain tissue models and data tools for drug research.
Product
Vale Biolabs combines human brain organoids, laboratory automation and predictive AI to study neurological diseases and potential treatments. Its tissue models reproduce selected features of the human brain for preclinical experiments.
The company tracks changes in tissue structure, activity and molecular responses over time and after drug exposure. It uses these measurements to build datasets and predictive models for researchers and drug developers.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Venture Kick Stage III convertible loan | CHF 100K | Venture Kick — Participant |